Newsroom
Category
June 17, 2021
Middle-aged people with depressive symptoms who carry a genetic variation called apolipoprotein (APOE) ε4 may be more at risk to develop tau protein accumulations in the brain’s emotion- and memory-controlling regions, a new study by researchers from UT Health San Antonio and collaborating institutions suggests.
June 17, 2021
Convalescent plasma therapy was associated with better survival in blood cancer patients hospitalized with COVID-19, especially in sicker patients. The findings by the COVID-19 and Cancer Consortium (CCC19) are newly published in the peer-reviewed journal JAMA Oncology.
June 17, 2021
UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19.
June 15, 2021
The Max and Minnie Tomerlin Voelcker Fund is awarding $800,000 to UT Health San Antonio to support research projects conducted by promising early career researchers.
June 2, 2021
Scientists from The University of Texas Health Science Center at San Antonio have discovered a mechanism by which SARS-CoV-2 exploits changes in metal ion concentrations to disguise itself in the body. Varying concentrations of metal ions — positively charged atoms such as magnesium, manganese and calcium — are observed in hospitalized COVID-19 patients.
May 25, 2021
The pandemic amplified mental health stressors long experienced by vulnerable Hispanic populations but also fortified members’ coping strategies, according to new research from the Center for Research to Advance Community Health.
